Paul Edward Walker

Filings by Paul Edward Walker span 13 companies, the busiest being Allakos Inc., Korro Bio, Inc. and NeueHealth, Inc. Over a trading history stretching from 28 June 2021 to 10 March 2026, the count stands at 17 filings.

The open-market side counts 6 purchases for €11.5M alongside 2 sales for €44k. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. In 2026 alone, the filings show 1 purchase and no sales.

A typical purchase (the median) is worth €2.0M. 5 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 12 March 2026: an open-market purchase of €2.0M, in Korro Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.